Territory Stories

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Details:

Title

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Collection

NT trends in ecstasy and related drug markets; Reports; PublicationNT

Date

2011

Description

Made available via the Publications (Legal Deposit) Act 2004 (NT).

Notes

Date:2011; Australian drug trends series No. 80

Language

English

Subject

Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication

Sydney (N.S.W)

ISBN

9780733430206

Copyright owner

Check within Publication or with content Publisher.

Parent handle

https://hdl.handle.net/10070/242182

Citation address

https://hdl.handle.net/10070/610318

Page content

30 Weekly or less continued to be the main pattern of use with overall patterns of use similar to those reported in previous years (Figure 16). Figure 16: Patterns of benzodiazepine use, 2003-2011 Source: IDRS participant interviews Table 23 demonstrates that in 2011 more than twice as many respondents used illicit benzodiazepines as used licit benzodiazepines. Alprazolam (Xanax) data is presented separately. Of the benzodiazepines listed below, diazepam (Valium) was used most often. Table 23: Forms of benzodiazepine most used and main brands, 2007-2011 2007 N=100 2008 N=106 2009 N=103 2010 N=99 2011 N=98 Used Most often Used Most often * Used Most often Used Most often Used Most often Licit (%) 34 11 32 27 32 21 34 27 13 Illicit (%) 33 20 40 28 33 18 28 22 28 Brand (%) Xanax / Kalma (alprazolam) 19 25 7 23 - Bromazepam (generic) 0 0 0 Valium (diazepam) 14 18 10 18 25 Hypnodorm (flunitrazepam) 1 2 2 1 Murelax (oxazepam) 0 1 0 Serepax (oxazepam) 1 0 1 2 5 Normison (temazepam) 0 0 2 2 0 Stilnox (zolpidem) 0 0 0 Rohypnol 0 0 2 0 Other 9 1 2 1 4 Source: IDRS participant interview 0 10 20 30 40 50 60 2003 2004 2005 2006 2007 2008 2009 2010 2011 % p ar ti ci p an ts No recent use Weekly or less More than weekly, less than daily Daily